PTA球囊導管市場（依材料類型、應用、最終用戶和地區）2024-2031

PTA球囊導管市場評估 - 2024-2031

PTA（經皮血管成形術）球囊導管市場受到心血管疾病發病率上升、微創治療需求增加、球囊導管技術進步以及周邊動脈疾病（PAD）治療意識不斷增強的推動，預計將推動市場規模在 2024 年超過 29.8 億美元，到 2031 年達到約 11.6 億美元。

市場主要參與企業包括Medtronic、波士頓科學公司、雅培實驗室和庫克醫療。北美和歐洲憑藉其先進的醫療基礎設施成為市場領先地區，而亞太地區預計將因醫療設施的改善和醫療成本的上升而顯著成長。受PTA球囊導管需求不斷成長的推動，預計2024年至2031年期間市場複合年成長率將達到9.70%。

PTA球囊導管市場定義/概述

PTA（經皮腔內血管成形術）球囊導管是醫療設備。它由一根軟性導管組成，導管尖端有一個小球囊，球囊充氣後可將斑塊壓向血管壁，促進血液循環。

PTA球囊導管用於經經皮血管成形術 (PTA)，以打開狹窄或阻塞的血管（通常是動脈），恢復正常的血流。 PTA對於治療周邊動脈疾病(PAD) 等疾病、改善血液循環以及緩解患肢疼痛和痙攣等症狀至關重要。

由於心血管疾病發病率上升、微創手術的進步以及老年人口的成長，預計經皮腔內血管成形術 (PTA) 球囊導管的未來使用將會增加，所有這些都推動了對有效血管干預的需求，以改善患者的治療效果並縮短恢復時間。

對聚氨酯材料類型的日益成長的偏好是否會推動 PTA 球囊導管市場的成長？

PTA球囊導管中聚氨酯的日益普及預計將推動市場擴張。聚氨酯因其生物相容性、柔韌性和耐用性而廣受歡迎，是醫療應用的理想選擇。其能貼合各種解剖特徵，提高了球囊導管治療血管疾病的有效性。

此外，聚氨酯具有抗穿刺和抗撕裂的特性，使導管不易斷裂，從而提高了患者的安全性和治療效果。材料科學的進步有望進一步提升聚氨酯導管的性能，從而增加其在醫療產業的應用。這一趨勢，加上心血管疾病發生率的上升和對微創手術的需求，預計將顯著推動PTA球囊導管市場的發展。

與導管治療相關的風險和併發症是否會阻礙 PTA 球囊導管市場？

導管治療相關的風險和危險可能會阻礙PTA球囊導管市場的擴張。感染疾病、血管損傷、血栓症和血管再阻塞都是潛在的併發症，會阻礙患者和醫護人員接受這些治療。此外，安全有效地進行導管治療需要專業知識，這使得聘請熟練的醫護人員變得困難，這可能會阻礙市場的成長。

對惡意事故的擔憂可能會導致監管審查力度加大、核准流程更加嚴格，以及新產品上市延遲。此外，患者對非侵入性治療的偏好可能會抑制對PTA球囊導管的需求。為了克服這些障礙，持續改善導管設計、改善手術流程並加強病患監測對於確保更安全、更有效的治療結果並維持市場成長至關重要。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概況
• 市場亮點

第3章 市場概況

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析

4. PTA球囊導管市場（依產品類型）

• 傳統球囊導管
• 藥物塗層球囊導管
• 藥物釋放型球囊導管

5. PTA球囊導管市場（依應用）

• 冠狀動脈疾病
• 周邊動脈疾病
• 腎動脈疾病
• 其他

6. PTA球囊導管市場（依最終用戶）

• 醫院
• 門診手術中心（ASC）
• 專科診所

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機遇
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市佔率分析

第10章：公司簡介

• Medtronic plc
• Terumo Corporation
• Boston Scientific Corporation
• Natec Medical
• Cardinal Health
• Cook Medical
• Biotronik
• Abbott
• Andratec
• Surmodics, Inc.

第11章 市場展望與機遇

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

PTA Balloon Catheter Market Valuation - 2024-2031

The PTA (Percutaneous Transluminal Angioplasty) Balloon Catheter Market is being driven by rising cardiovascular disease prevalence, increased demand for minimally invasive procedures, technological advancements in balloon catheters, and growing awareness of peripheral artery disease (PAD) treatments. This is likely to enable the market size surpass USD 2.98 Billion valued in 2024 to reach a valuation of around USD 1.16 Billion by 2031.

Medtronic, Boston Scientific Corporation, Abbott Laboratories and Cook Medical are among the market's leading participants. North America and Europe are the leading regions due to sophisticated healthcare infrastructure, but the Asia-Pacific region is predicted to increase significantly as healthcare facilities improve and healthcare expenditure rises. The rising demand for PTA balloon catheter is enabling the market grow at a CAGR of 9.70% from 2024 to 2031.

PTA Balloon Catheter Market: Definition/ Overview

A PTA (Percutaneous Transluminal Angioplasty) balloon catheter is a medical device used to widen blood arteries that are restricted or occluded. It consists of a flexible catheter with a tiny balloon at the tip that is inflated to compress plaque against the vascular wall, so increasing blood circulation.

PTA balloon catheters are used in percutaneous transluminal angioplasty (PTA) to widen narrowed or obstructed blood vessels, usually arteries, and restore appropriate blood flow. They are critical for treating illnesses such as peripheral artery disease (PAD), increasing circulation, and alleviating symptoms such as pain and cramping in affected limbs.

The future use of PTA (Percutaneous Transluminal Angioplasty) balloon catheters is expected to increase due to rising cardiovascular disease rates, advances in minimally invasive procedures and a growing geriatric population, all of which are driving demand for effective vascular interventions with better patient outcomes and shorter recovery times.

Will Increasing Preference of Polyurethane Material Type Boost the PTA Balloon Catheter Market Growth?

The growing choice for polyurethane in PTA balloon catheters is expected to drive market expansion. Polyurethane is popular because of its high biocompatibility, flexibility, and durability, making it ideal for medical applications. Its capacity to conform to varied anatomical features increases the effectiveness of balloon catheters in treating vascular diseases.

Furthermore, polyurethane's resilience to punctures and tears lowers the likelihood of catheter failure, which improves patient safety and outcomes. As material science advances, polyurethane-based catheters are predicted to function even better, increasing their use in the medical industry. This trend, together with the rising incidence of cardiovascular illnesses and the demand for minimally invasive procedures, will significantly boost the PTA balloon catheter market.

Will Risk and Complication Associated with Catheterization Procedures Hamper the PTA Balloon Catheter Market?

Risks and hazards connected with catheterization operations may impede the expansion of the PTA balloon catheter market. Infections, vascular injury, thrombosis, and restenosis are all potential complications that may prevent patients and healthcare providers from undergoing these treatments. Furthermore, the need for specialized expertise to execute catheterizations safely and successfully may limit the availability of skilled practitioners, weighing on market growth.

Concerns about bad incidents may result in increased regulatory scrutiny and tougher approval processes, thereby delaying the launch of new goods. Furthermore, patients' desire for non-invasive options may diminish demand for PTA balloon catheters. To address these obstacles, continued advances in catheter design, improved procedural procedures, and greater patient monitoring are critical to assuring safer and more effective outcomes, which will sustain market growth.

Category-Wise Acumens

Will Superior Biocompatibility and Flexibility Drive the Polyurethane Segment?

The enhanced biocompatibility and flexibility are key factors boosting the polyurethane segment of the PTA balloon catheter market. Polyurethane's biocompatibility reduces the chance of adverse responses in patients, making it a favoured material for medical equipment. Its suppleness enables the balloon catheter to more successfully negotiate intricate arterial paths, increasing the overall efficacy of the treatment. These qualities not only improve patient safety, but also optimize catheter function during interventions.

Furthermore, polyurethane's resilience and resistance to punctures or tears add to its increasing popularity. As the demand for minimally invasive procedures rises, polyurethane's benefits over other materials are projected to fuel segment dominance, resulting in greater market adoption and innovation in catheter technology.

Will Higher Prevalence and the Need for Frequent Interventions Drive the Application Segment?

The increasing prevalence of coronary artery disease (CAD) and the requirement for frequent interventions will boost the application sector of the PTA balloon catheter market. CAD is a primary cause of cardiovascular events, necessitating the routine use of PTA balloon catheters for angioplasty treatments to restore blood flow and relieve symptoms.

The increasing prevalence of CAD creates a huge demand for effective and dependable treatment alternatives. Furthermore, frequent interventions for CAD patients encourage continued use and improvement in PTA balloon catheter devices. As the population ages and lifestyle-related risk factors increase, the need for these operations is likely to rise. This trend is projected to drive continuous market expansion for PTA balloon catheters, particularly in the coronary artery disease application category. Thus, enabling the segment hold major share in the market growth over the forecast period.

ropel the PTA balloon catheter market in North America. Cardiovascular disorders, such as coronary artery disease and peripheral artery disease, are among the region's most pressing health concerns, necessitating an increase in demand for efficient treatment alternatives. The enormous patient population necessitates frequent interventions, increasing the demand for PTA balloon catheters.

Furthermore, North America's excellent healthcare infrastructure and rapid technological adoption encourage the use of novel medical equipment. The existence of significant medical device manufacturers and robust healthcare policies contribute to market growth. As knowledge of cardiovascular health increases and treatment options expand, the market for PTA balloon catheters in North America is likely to dominate over the forecast period.

Will Improving Healthcare Access in Emerging Economies Drive the Market in Asia Pacific Region?

Increasing healthcare access in emerging economies will drive the Asia-Pacific PTA balloon catheter market. As healthcare infrastructure improves and access to medical services grows, more patients in these economies receive prompt therapies for cardiovascular illnesses. Rising awareness and government measures to improve healthcare delivery contribute to more use of modern medical devices, such as PTA balloon catheters.

Furthermore, the increasing prevalence of cardiovascular disorders in these locations raises the demand for better treatment alternatives. Increased investment in healthcare facilities, combined with the development of low-cost medical gadgets, drives market expansion. As these economies expand their healthcare capacities, Asia-Pacific's PTA balloon catheter market is likely to rise significantly.

Competitive Landscape

The PTA balloon catheter market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the PTA balloon catheter market include:

Medtronic plc

Terumo Corporation

Boston Scientific Corporation

Natec Medical

Cardinal Health

Cook Medical

Biotronik

Abbott

Andratec

Surmodics, Inc.

PTA Balloon Catheter Market Latest Developments

In January 2024, Cook Medical announced that its Slip-Cath Beacon Tip hydrophilic selective catheter is now available in the United States and Canada.

In June 2023, Cook Medical expanded its Advance Serenity hydrophilic percutaneous transluminal angioplasty balloon catheter product line with new sizes and locations.

In March 2023, BrosMed received CE MDR approval for its Tiche 0.035 High-Pressure PTA Balloon Dilatation Catheter. The catheter is intended to treat severe calcified peripheral vascular disease and hard AV cases under the European Medical Device Regulation (MDR).

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. PTA Balloon Catheter Market, By Product Type

• Normal Balloon Catheters
• Drug-Coated Balloon Catheters
• Drug-Eluting Balloon Catheters

5. PTA Balloon Catheter Market, By Application

• Coronary Artery Disease
• Peripheral Artery Disease
• Renal Artery Disease
• Others

6. PTA Balloon Catheter Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• Terumo Corporation
• Boston Scientific Corporation
• Natec Medical
• Cardinal Health
• Cook Medical
• Biotronik
• Abbott
• Andratec
• Surmodics, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References